Literature DB >> 7196809

Soybean diet lowers breast tumor incidence in irradiated rats.

W Troll, R Wiesner, C J Shellabarger, S Holtzman, J P Stone.   

Abstract

This paper examines the relationship between feeding a diet rich in protease inhibitors and the reduction of mammary cancer induced by x-irradiation in Sprague-Dawley rats. Of a total of 145 irradiated animals, 44% of the 45 rats fed a raw soybean diet containing a high concentration of protease inhibitor developed mammary tumors as compared to 74% of 50 rats fed a casein diet containing no protease inhibitor. Animals fed Purina rat chow which contained low levels of protease inhibitor exhibited a 70% mammary tumor incidence. No spontaneous neoplasms were found in any of the non-irradiated animals on the raw soybean diet whereas about 10% of the animals on the protease-free diet developed tumors. Thus, soybeans which are rich in protease inhibitors reduced the induction of mammary cancer in x-irradiated rats. This work suggests that diets rich in protease inhibitors may contribute to reducing cancer incidence in man.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7196809     DOI: 10.1093/carcin/1.6.469

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  12 in total

1.  Beneficial effects of soy protein in the initiation and progression against dimethylbenz [a] anthracene-induced breast tumors in female rats.

Authors:  Sutapa Mukhopadhyay; Billy R Ballard; Shyamali Mukherjee; Syeda M Kabir; Salil K Das
Journal:  Mol Cell Biochem       Date:  2006-06-20       Impact factor: 3.396

2.  The chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancer.

Authors:  Nadine M Brown; Carrie A Belles; Stephanie L Lindley; Linda D Zimmer-Nechemias; Xueheng Zhao; David P Witte; Mi-Ok Kim; Kenneth D R Setchell
Journal:  Carcinogenesis       Date:  2010-01-28       Impact factor: 4.944

3.  Genistein, a dietary-derived inhibitor of in vitro angiogenesis.

Authors:  T Fotsis; M Pepper; H Adlercreutz; G Fleischmann; T Hase; R Montesano; L Schweigerer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

4.  Complementary roles in cancer prevention: protease inhibitor makes the cancer preventive peptide lunasin bioavailable.

Authors:  Chia-Chien Hsieh; Blanca Hernández-Ledesma; Hyun Jin Jeong; Jae Ho Park; Ben O de Lumen
Journal:  PLoS One       Date:  2010-01-26       Impact factor: 3.240

5.  Protease inhibitors reduce the frequency of spontaneous chromosome abnormalities in cells from patients with Bloom syndrome.

Authors:  A R Kennedy; B S Radner; H Nagasawa
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

Review 6.  Mitigating the risk of radiation-induced cancers: limitations and paradigms in drug development.

Authors:  Stephen S Yoo; Timothy J Jorgensen; Ann R Kennedy; John D Boice; Alla Shapiro; Tom C-C Hu; Brian R Moyer; Marcy B Grace; Gary J Kelloff; Michael Fenech; Pataje G S Prasanna; C Norman Coleman
Journal:  J Radiol Prot       Date:  2014-04-14       Impact factor: 1.394

7.  Molecular cloning and characterization of genistein 4'-O-glucoside specific glycosyltransferase from Bacopa monniera.

Authors:  R J Santosh Kumar; Rishi K Vishwakarma; Somesh Singh; Bashir M Khan
Journal:  Mol Biol Rep       Date:  2014-03-25       Impact factor: 2.316

8.  Vegetables, fruit, and cancer. I. Epidemiology.

Authors:  K A Steinmetz; J D Potter
Journal:  Cancer Causes Control       Date:  1991-09       Impact factor: 2.506

9.  Isoflavones inhibit intestinal epithelial cell proliferation and induce apoptosis in vitro.

Authors:  C Booth; D F Hargreaves; J A Hadfield; A T McGown; C S Potten
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

Review 10.  Cancer risk assessment and prevention: where do we stand?

Authors:  A S Whittemore
Journal:  Environ Health Perspect       Date:  1989-05       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.